Avita Medical Overview
- Year Founded
-
1993
- Status
-
Public
- Employees
-
226
- Stock Symbol
-
RCEL
- Investments
-
1
- Share Price
-
$15.62
- (As of Friday Closing)
Avita Medical General Information
Description
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Contact Information
Website
www.avitamedical.comCorporate Office
- 28159 Avenue Stanford
- Suite 220
- Valencia, CA 91355
- United States
Corporate Office
- 28159 Avenue Stanford
- Suite 220
- Valencia, CA 91355
- United States
Avita Medical Timeline
Avita Medical Stock Performance
As of 20-Nov-2026, Avita Medical’s stock price is $15.62. Its current market cap is $495M with 31.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $15.62 | $15.99 | $3.22 - $18.43 | $495M | 31.7M | 416K | -$1.18 |
Avita Medical Financials Summary
As of 30-Sep-2026, Avita Medical has a trailing 12-month revenue of $84.7M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 400,118 | 126,661 | 337,031 | 293,816 |
| Revenue | 84,682 | 71,610 | 64,251 | 50,143 |
| EBITDA | (28,540) | (41,246) | (55,425) | (33,767) |
| Net Income | (36,117) | (48,587) | (61,845) | (35,381) |
| Total Assets | 46,794 | 56,392 | 79,711 | 111,640 |
| Total Debt | 47,134 | 46,048 | 45,985 | 42,409 |
Avita Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Avita Medical Comparisons
Industry
Financing
Details
Avita Medical Competitors (1)
One of Avita Medical’s competitors is NovaBone, a Private Equity-Backed company based in Alachua, FL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NovaBone | Private Equity-Backed | Alachua, FL |
Avita Medical Patents
Avita Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-6479757-B2 | System and method for performing tissue processing and preparation of its cell suspension | Active | 14-Mar-2013 | ||
| JP-2016512689-A | System and method for performing tissue treatment and cell suspension preparation thereof | Active | 14-Mar-2013 | ||
| CA-2906088-A1 | Systems and methods for tissue processing and preparation of cell suspension therefrom | Pending | 14-Mar-2013 | ||
| WO-2014153072-A1 | Systems and methods for tissue processing and preparation of cell suspension therefrom | Inactive | 14-Mar-2013 | ||
| US-20150079153-A1 | Cell suspension and use thereof | Inactive | 22-Mar-2012 | A61L15/36 |
Avita Medical Signals
Avita Medical Investments (1)
Avita Medical’s most recent deal was a Corporate Asset Purchase with Manufacturing plant (Ventura). The deal was made on 01-Jul-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Manufacturing plant (Ventura) | 01-Jul-2018 | Corporate Asset Purchase | Buildings and Property |
Avita Medical ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
29.78 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Avita Medical FAQs
-
When was Avita Medical founded?
Avita Medical was founded in 1993.
-
Where is Avita Medical headquartered?
Avita Medical is headquartered in Valencia, CA.
-
What is the size of Avita Medical?
Avita Medical has 226 total employees.
-
What industry is Avita Medical in?
Avita Medical’s primary industry is Therapeutic Devices.
-
Is Avita Medical a private or public company?
Avita Medical is a Public company.
-
What is Avita Medical’s stock symbol?
The ticker symbol for Avita Medical is RCEL.
-
What is the current stock price of Avita Medical?
As of 20-Nov-2026 the stock price of Avita Medical is $15.62.
-
What is the current market cap of Avita Medical?
The current market capitalization of Avita Medical is $495M.
-
What is Avita Medical’s current revenue?
The trailing twelve month revenue for Avita Medical is $84.7M.
-
Who are Avita Medical’s competitors?
NovaBone is a competitor of Avita Medical.
-
What is Avita Medical’s annual earnings per share (EPS)?
Avita Medical’s EPS for 12 months was -$1.18.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process